Better AI Stock: SpaceX or Palantir?

The article favors SpaceX over Palantir as an AI investment, citing xAI revenue growth of 213% year over year and projected SpaceX-wide revenue growth of 153% next year, versus Palantir's expected 50% growth. Both companies carry elevated valuations—SpaceX at roughly 44x forward sales and Palantir at 55x—creating material expectation and valuation risk. The thesis is that SpaceX offers faster anticipated growth at a lower sales multiple, although it is opinion-based rather than a company announcement.

Analysis

The relevant distinction is not application category but unit economics and capital intensity. PLTR monetizes embedded workflow software with high switching costs and a comparatively legible path from bookings to recurring gross profit; SPCX’s implied AI exposure is bundled with launch, satellite, and model-training capital needs, making headline growth a poor proxy for free-cash-flow conversion. If public-market investors begin separating infrastructure cash generation from AI burn, SPCX could face a sharper multiple reset despite faster top-line growth.

PLTR’s principal risk over the next 1-3 months is not demand collapse but expectations: at an extreme sales multiple, even a modest deceleration in U.S. commercial net-new customer growth, remaining-deal value, or operating-margin expansion can drive disproportionate de-rating. Conversely, enterprise AI buyers often prefer integration, security, governance, and accountable deployment over frontier-model optionality; that favors PLTR, Microsoft (MSFT), and ServiceNow (NOW) over a pure model-provider narrative. The article’s claimed growth and valuation figures should be independently verified before any position is sized.

The contrarian view is that a bundled SPCX/xAI equity story may be underpricing internal cross-subsidization and concentration risk rather than offering a cheaper AI multiple. Frontier models increasingly commoditize at the API layer, while inference cost, distribution, proprietary data, and enterprise implementation determine durable returns. Over 6-18 months, the likely winners are firms that either sell scarce compute/network capacity (NVDA, AVGO) or capture enterprise workflow budgets; standalone model valuation will remain vulnerable to rapid capability convergence and escalating capex.

Key Decisions for Investors

• No outright SPCX long until audited segment disclosure separates xAI revenue, training/inference capex, gross margin, and related-party economics from the core business. Treat confirmation of positive AI contribution margin and identifiable external enterprise revenue as the entry trigger, not reported consolidated growth.
• Maintain PLTR as a tactical short/watch rather than a structural short over the next earnings cycle: initiate only if U.S. commercial growth or remaining-deal-value growth decelerates materially while valuation remains near current premium levels. Cover on raised full-year revenue guidance plus sustained operating-margin expansion; upside squeeze risk is high given retail momentum and government-contract optionality.
• For a liquid relative-value expression after SPCX trading history is established, consider long PLTR / short SPCX only if SPCX’s valuation premium persists despite lower disclosed free-cash-flow conversion. Use a 3-6 month horizon and limit gross exposure until borrow availability, float, and index flows are known.
• Prefer NVDA or AVGO exposure over unverified frontier-model beta for 6-18 months: model competition increases demand for accelerators, networking, and custom silicon even if individual model vendors fail to monetize. Reassess if hyperscaler capex guidance rolls over or accelerator lead times normalize sharply.